Mercados españoles cerrados

QuidelOrtho Corporation (QDEL)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
94,26+0,61 (+0,65%)
Al cierre: 04:00PM EST
93,87 -0,39 (-0,41%)
Después del cierre: 04:32PM EST

QuidelOrtho Corporation

9975 Summers Ridge Road
San Diego, CA 92121
United States
858 552 1100
https://www.quidelortho.com

Sector(es)Healthcare
SectorMedical Instruments & Supplies
Empleados a tiempo completo1600

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Douglas C. BryantChairman & CEO1,41MN/A1958
Mr. Robert J. Bujarski J.D.Pres & COO770,62kN/A1969
Ms. Michelle A. HodgesGen. Counsel620,61kN/A1960
Dr. Werner Kroll Ph.D.Sr. VP of R&D758,22k2,1M1957
Mr. Joseph M. Busky CPAChief Financial OfficerN/AN/A1968
Ms. Louise BrandyChief Information OfficerN/AN/AN/A
Mr. Patrick E. KleinChief Admin. OfficerN/AN/AN/A
Ruben ArguetaDirector of Investor RelationsN/AN/AN/A
Mr. Michael S. IskraChief Commercial OfficerN/AN/A1970
Dr. Chockalingam Palaniappan Ph.D.Chief Innovation OfficerN/AN/A1965
Los importes son a partir de 31 de diciembre de 2021 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; and analyzers and amplification systems. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

Gobierno corporativo

El ISS Governance QualityScore de QuidelOrtho Corporation, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.